Martyn Boutelle

Professor of Biomedical Sensors Engineering, Imperial College London

Martyn Boutelle is Professor of Biomedical Sensors Engineering in the Department of Bioengineering, Imperial College London, and Associate Provost for Estates Planning for Imperial College.
His research group is multidisciplinary comprising, bioengineers, scientists, and clinicians. He develops novel analytical science methods using microfluidics, electrochemical sensors / biosensors, and wireless electronics to make portable (sometimes wearable) monitoring devices for use as point of care devices that typically giving continuous real -time displays. He then uses these in a program of clinical science research focusing on the acute traumatic brain injury including that caused by cardiac arrest, neonatal continuous monitoring and kidney transplantation monitoring. He runs the EPSRC funded Bio-nanofabrication suite designed to make microfluidic and biosensor biosensors using scalable methods to allow use in proof-of-concept clinical trials.

Martyn is past president of the International Society for Monitoring Molecules in Neuroscience, and a founder of the COSBID organization for studying acute human brain injury. He published > 190 papers, chapters and patents. He obtained a BSc and PhD in Chemistry from Imperial College and worked as an EP Abraham Research Fellow in the University of Oxford.

Nils Paust

Head of Division Microfluidic Platforms, Hahn-Schickard-Gesellschaft für Angewandte Forschung eV

PD Dr Nils Paust has a background in energy and process engineering. He received his PhD on the topic of micro fuel cells at the University of Freiburg in 2010. In February 2010, he joined the lab-on-chip research activities at Hahn-Schickard in Freiburg, first as a group leader, then as head of division microfluidic platforms and nowadays as an executive board member of Hahn-Schickard. In 2020, he completed his habilitation and co-founded the Dermagnostix GmbH in 2021. Main research interest of Nils Paust is the centrifugal microfluidic system integration. This comprises new microfluidic functionalities, cost-efficient mass fabrication of microfluidic chips and the implementation of complete laboratory workflows on centrifugal microfluidic platforms.

Menno Prins

Professor, Eindhoven University of Technology & Helia BioMonitoring

Erik Vollebregt

Partner, Axon Lawyers

Erik specializes in EU and national legal and regulatory issues relating to medical devices, including eHealth, mHealth, software and protection of personal data. He is an expert in life sciences regulation at EU and Dutch level, with a focus on contracts, regulatory litigation against competent authorities and M&A. Erik was initially trained as intellectual property and competition lawyer, starting his career at the Directorate-General for Competition of the European Commission. He subsequently gained experience in contentious matters, commercial contracts, and transactional work at three large international law firms. He actively contributes to law and policy development at national and EU level via membership of specialized committees at branch associations and the European Commission. Erik also works as arbitrator in medical devices related disputes and is regularly retained as expert witness in foreign litigation.